Articles

Sort by
Previous Page Page 2 of 2 Next Page
  1. Letter to the Editor

    Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics

    149Tb represents a powerful alternative to currently used α-emitters: the relatively short half-life (T1/2 = 4.1 h), low α-energy (3.97 MeV, Iα = 16.7 %), absence of α-emitting daughters ...

    Cristina Müller, Christiaan Vermeulen, Ulli Köster, Karl Johnston, Andreas Türler, Roger Schibli and Nicholas P. van der Meulen

    EJNMMI Radiopharmacy and Chemistry 2016 1:5

    Published on: 28 March 2016

  2. Research

    Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission

    Phosphodiesterase 10A (PDE10A) is an important regulator of nigrostriatal dopamine (DA) neurotransmission. However, little is known on the effect of alterations in DA neurotransmission on PDE10A availability. ...

    Maarten Ooms, Sofie Celen, Ronald De Hoogt, Ilse Lenaerts, Johnny Liebregts, Greet Vanhoof, Xavier Langlois, Andrey Postnov, Michel Koole, Alfons Verbruggen, Koen Van Laere and Guy Bormans

    EJNMMI Radiopharmacy and Chemistry 2016 1:3

    Published on: 21 March 2016

  3. Position paper

    Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals

    This is a position paper of the Radiopharmacy Committee of the EANM (European Association of Nuclear Medicine) addressing toxicology studies for application of new diagnostic and therapeutic radiopharmaceutica...

    J. Koziorowski, M. Behe, C. Decristoforo, J. Ballinger, P. Elsinga, V. Ferrari, P. Kolenc Peitl, S. Todde and T. L. Mindt

    EJNMMI Radiopharmacy and Chemistry 2016 1:1

    Published on: 21 March 2016

Previous Page Page 2 of 2 Next Page

Upcoming events

EANM'17

Related websites

Searching for an article? Easily browse the EJNMMI journals on the Nuclear Medicine and Molecular Imaging webportal.